Accord Logo

Intended for UK patients and members of the public

Co-codamol 8/500mg Tablets - PL 20075/0702

Co-codamol 8/500mg Tablets - PL 20075/0702

PL Number:
20075/0702
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Description of update: 1) To update section 4.4 of the SmPC in line with the MHRA letter (Annex 1) - review of the CMDh recommended warnings for Opioid Use Disorder (OUD).

    2) To update sections 4.2, 4.4, 4.5 and 4.8 of the SmPC and sections 2, 3, 4 and 5 PIL in line with PSUSA/00000851/202503 for codeine/paracetamol containing medicines to include the following information: interactions with gabapentinoids, Sphincter of Oddi dysfunction, hyperalgesia, central sleep apnoea (CSA), opioid drug disorder (OUD), storage information. In addition, a spelling has been corrected in SmPC section 4.3 and the leaflet/labelling wording in section 4.4 has been aligned with the current approved text.

    Date of approval: 30/04/2026

    PIL sections updated: 2, 3, 4, 5 and 6

  • Description of update:

    1) To update section 4.4 of the SmPC in line with the MHRA letter (Annex 1) - review of the CMDh recommended warnings for Opioid Use Disorder (OUD).

    2) To update sections 4.2, 4.4, 4.5 and 4.8 of the SmPC and sections 2, 3, 4 and 5 PIL in line with PSUSA/00000851/202503 for codeine/paracetamol containing medicines to include the following information: interactions with gabapentinoids, Sphincter of Oddi dysfunction, hyperalgesia, central sleep apnoea (CSA), opioid drug disorder (OUD), storage information. In addition, a spelling has been corrected in SmPC section 4.3 and the leaflet/labelling wording in section 4.4 has been aligned with the current approved text.

    Date of approval: 30/04/2026

    SmPC sections updated: 4.2, 4.3, 4.4, 4.5, 4.8 and 10

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

For any further assistance, please get in touch.

View product information as a: